Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population

CompletedOBSERVATIONAL
Enrollment

9,906

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate

fluticasone propionate 44 mcg

DRUG

Budesonide

budesonide

DRUG

Montelukast

montelukast

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY